Jacobi Capital Management LLC Novavax Inc Transaction History

Jacobi Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $76,295 - $123,588	-567 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $54,584 - $83,068	307 Added 118.08%	567 $118,000
Q1 2021 May 11, 2021	BUY	$112.98 - $319.93 $29,374 - $83,181	260 New	260 $47,000
Q4 2020 Feb 08, 2021	SELL	$78.74 - $139.5 $15,747 - $27,900	-200 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$79.44 - $178.51 $63,552 - $142,808	-800 Reduced 80.0%	200 $22,000
Q2 2020 Aug 04, 2020	BUY	$13.86 - $83.61 $13,610 - $82,105	982 Added 5455.56%	1,000 $83,000
Q2 2020 Jul 27, 2020	BUY	$13.86 - $83.61 $249 - $1,504	18 New	18 $83,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.